Related Experiment Video
Updated: Oct 11, 2025

Whole-body PET/MRI of Pediatric Patients: The Details That Matter
Published on: December 19, 2017
[Follow-up imaging in children with rhabdomyosarcoma: less scans, the same yield]
Bas Vaarwerk1,2, Rick R van Rijn3, Johannes H M Merks4
1Amsterdam UMC, Emma Kinderziekenhuis, afd. Kinderoncologie, Amsterdam.
Insights
Frequent imaging for rhabdomyosarcoma relapse detection in children had limited clinical value. Most relapses were identified by symptoms, leading to revised guidelines with 50% fewer imaging exams and a 2-year follow-up period.
Area of Science:
- Pediatric Oncology
- Radiology
- Clinical Trial Design
Background:
- Children with rhabdomyosarcoma undergo regular follow-up imaging to detect relapses.
- The clinical utility of frequent imaging in rhabdomyosarcoma follow-up requires evaluation.
Purpose of the Study:
- To assess the clinical value of radiologic imaging in detecting rhabdomyosarcoma relapse.
- To inform updated follow-up guidelines for pediatric rhabdomyosarcoma patients.
Main Methods:
- Retrospective analysis of imaging and clinical data in rhabdomyosarcoma patients.
- Evaluation of relapse detection rates via imaging versus clinical symptoms.
- Development and implementation of a new follow-up protocol.
Main Results:
- The majority of rhabdomyosarcoma relapses were detected through clinical symptoms, not imaging.
- Frequent imaging protocols showed limited additional diagnostic value for relapse detection.
- A revised follow-up guideline was successfully implemented, reducing imaging frequency by 50%.
Conclusions:
- Clinical surveillance is paramount for rhabdomyosarcoma relapse detection in children.
- Reduced frequency of imaging in follow-up protocols is feasible and effective.
- Updated European guidelines now incorporate these findings, optimizing patient care and resource allocation.
Abstract:
Children treated for rhabdomyosarcoma are subject to protocolized follow-up imaging to detect a potential relapse earlier and to improve the chances of survival in case of a relapse. In this study we report on our findings concerning the clinical value of radiologic imaging in patients with rhabdomyosarcoma. We showed that the majority of relapses were detected by clinical symptoms, despite the frequent imaging. These results were used to define a new follow-up recommendation that was successfully implemented in the current European paediatric Soft tissue sarcoma Study Group guideline. In this new recommendation we reduced the number of radiologic imaging examinations performed after end-of-therapy by 50%, and decreased the follow-up time after end-of-therapy to 2 years.
More Related Videos
11:31Using Micro-computed Tomography for the Assessment of Tumor Development and Follow-up of Response to Treatment in a Mouse Model of Lung Cancer
Published on: May 20, 2016
08:55Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
Published on: November 2, 2014